HomeCoronary diseaseChronic Ischemic cardiopathy

Chronic Ischemic cardiopathy

Ver Categoría

Chronic Ischemic cardiopathy

EuroPCR 2018 | FAME 2: FFR Shows 5-Year Benefit for Hard Endpoints

After a 5-year follow-up, and for the first time, functional assessment with fractional flow reserve (FFR) showed...
solaci -
Ver más
Chronic Ischemic cardiopathy

EuroPCR 2018 | ORBITA: The Link Between Ischemia and Symptoms Is Still Not Entirely Understood

Invasive physiology tests used in the ORBITA trial could not predict which patients would benefit from angioplasty...
solaci -
Ver más
Chronic Ischemic cardiopathy

EuroPCR 2018 | SYNTAX III REVOLUTION: Excellent Correlation Between Angiography and Computerized Tomography in Patients with Left Main and Multivessel Disease

In patients with left main or three-vessel coronary disease, heart team decisions on revascularization strategy (angioplasty or...
solaci -
Ver más
Chronic Ischemic cardiopathy

EuroPCR 2018 | SCAAR Registry at 10 years: FFR improves decision making in the long term

The SCAAR registry aimed at showing the differences in mortality at very long term when using functional...
solaci -
Ver más
Chronic Ischemic cardiopathy

Maintaining Physical Activity After an Acute Myocardial Infarction Reduces Mortality

Performing a successful primary angioplasty and prescribing preventive medication without advising on the importance of keeping up...
solaci -
Ver más
Chronic Ischemic cardiopathy

Restenosis Does Not Seem as Benign as We Thought

Elective, uncomplicated repeat revascularization after stent restenosis is associated with higher mortality rates according to a new...
solaci -
Ver más
Chronic Ischemic cardiopathy

Hybrid Revascularization or Conventional Surgery: History Is Still Being Written

Hybrid revascularization seems to achieve results similar to those of conventional myocardial revascularization surgery at 5 years, although...
solaci -
Ver más
Chronic Ischemic cardiopathy

ACC 2018 | DEFINE-FLAIR Sub-Analysis: iFR More Comfortable, Faster, and Much Cheaper

Using instantaneous wave-free ratio (iFR) to guide decisions on revascularization of intermediate lesions is cheaper than using...
solaci -
Ver más